Skip to main content

Reply to Comments on "Beyond P-value: the Rigor and Power of Study"

Publication ,  Journal Article
Zhang, F; Hughes, C
Published in: Global Clinical and Translational Research
January 10, 2020

We received commentaries that included comments on our paper. Here we provide replies to the comments in the order received. To avoid confusion, we made a revision in the Table 1 to assure that level of significance and power at specified effect size are used appropriately.

Duke Scholars

Published In

Global Clinical and Translational Research

DOI

EISSN

2643-8151

ISSN

2641-7154

Publication Date

January 10, 2020

Start / End Page

13 / 15

Publisher

Global Clinical and Translational Research Institute
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Zhang, F., & Hughes, C. (2020). Reply to Comments on "Beyond P-value: the Rigor and Power of Study". Global Clinical and Translational Research, 13–15. https://doi.org/10.36316/gcatr.02.0025
Zhang, Fengyu, and Claude Hughes. “Reply to Comments on "Beyond P-value: the Rigor and Power of Study".” Global Clinical and Translational Research, January 10, 2020, 13–15. https://doi.org/10.36316/gcatr.02.0025.
Zhang F, Hughes C. Reply to Comments on "Beyond P-value: the Rigor and Power of Study". Global Clinical and Translational Research. 2020 Jan 10;13–5.
Zhang, Fengyu, and Claude Hughes. “Reply to Comments on "Beyond P-value: the Rigor and Power of Study".” Global Clinical and Translational Research, Global Clinical and Translational Research Institute, Jan. 2020, pp. 13–15. Crossref, doi:10.36316/gcatr.02.0025.
Zhang F, Hughes C. Reply to Comments on "Beyond P-value: the Rigor and Power of Study". Global Clinical and Translational Research. Global Clinical and Translational Research Institute; 2020 Jan 10;13–15.

Published In

Global Clinical and Translational Research

DOI

EISSN

2643-8151

ISSN

2641-7154

Publication Date

January 10, 2020

Start / End Page

13 / 15

Publisher

Global Clinical and Translational Research Institute